An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake
NCT04280653 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2020-12-08
Summary
To evaluate the effect of the NDE L68 StableFit® punctal plug on the tear lake.
Conditions
- Dry Eye Syndromes
Interventions
- DEVICE
-
NDE L68 StableFit® Punctal Plug
Tear lake evaluation of the planned study eye, prior to insertion of the Punctal Plug and then tear lake evaluation at days 7 and 28 after punctal plug insertion.
Sponsors & Collaborators
-
Mati Therapeutics Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-08-28
- Primary Completion
- 2019-12-11
- Completion
- 2019-12-11
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
NCT03658811 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual Occlusion
NCT04022382 ·Status: COMPLETED ·Phase: NA
-
Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGD
NCT02621593 ·Status: COMPLETED ·Phase: NA
-
Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease
NCT03502447 ·Status: TERMINATED ·Phase: NA
-
Assessing the Impact of Tixel Treatment of Periorbital Wrinkles on Dry Eye Symptoms and Signs
NCT04730336 ·Status: COMPLETED ·Phase: NA
-
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
NCT05162261 ·Status: COMPLETED ·Phase: NA
-
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
NCT01808560 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of the Clinical Utility and Safety of the Visant Medical Canalicular Plug
NCT04817085 ·Status: COMPLETED ·Phase: NA
-
Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)
NCT05467293 ·Status: COMPLETED ·Phase: PHASE2
-
OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
NCT05814757 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Meibomian Gland Dysfunction and Dry Eye With an LED Blue Treatment Device
NCT03788486 ·Status: WITHDRAWN ·Phase: NA
-
LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease
NCT02365519 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Intense Pulsed Light for Improving Dry Eye Syndrome
NCT03396913 ·Status: COMPLETED ·Phase: NA
-
Comparison Between iLux and LipiFlow in the Treatment of Meibomian Gland Dysfunction (MGD): A 12-month, Multicenter Study
NCT03956225 ·Status: COMPLETED ·Phase: NA
-
Prospective Evaluation of Efficacy and Safety of an Intense Pulsed Light Device to Treat Dry Eye Disease"
NCT06349356 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of the TearCare System in Adults With Dry Eye Disease
NCT03006978 ·Status: COMPLETED ·Phase: NA
-
Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients
NCT05304637 ·Status: UNKNOWN ·Phase: PHASE4
-
A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.
NCT06244316 ·Status: COMPLETED ·Phase: PHASE2
-
The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression
NCT05713981 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
NCT05618730 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluating a Device for Blocking the Tear Duct
NCT05748951 ·Status: COMPLETED ·Phase: NA
-
The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Dry Eye Disease
NCT05203796 ·Status: COMPLETED ·Phase: NA
-
Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction
NCT03055832 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Effectiveness of Restylane-Defyne for Punctual Occlusion
NCT03709641 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Clinical Effects of Two Tear Substitutes in Patients With Dry Eye Syndrome
NCT02992392 ·Status: UNKNOWN ·Phase: NA